Phase II Trial of Sequential Chemotherapy and Radiotherapy for AIDS-Related Primary Central Nervous System Lymphoma [clinicaltrials:NCT00000801]
Phase II Trial of Sequential Chemotherapy and Radiotherapy for AIDS-Related Primary Central Nervous System Lymphoma [clinicaltrials:NCT00000801]
Bio2RDF identifier
NCT00000801
Bio2RDF namespace
clinicaltrials
Bio2RDF uri
http://bio2rdf.org/clinicaltrials:NCT00000801
identifiers.org URI
authority [clinicaltrials_vocabulary:authority]
brief summary [clinicaltrials_vocabulary:brief-summary]
To estimate the respons ...... d primary CNS
lymphoma.
brief title [clinicaltrials_vocabulary:brief-title]
Phase II Trial of Sequential C ...... entral Nervous System Lymphoma
completion date [clinicaltrials_vocabulary:completion-date]
1998-04-01T00:00:00Z
condition [clinicaltrials_vocabulary:condition]
condition browse [clinicaltrials_vocabulary:condition-browse]
condition mesh [clinicaltrials_vocabulary:condition-mesh]
country [clinicaltrials_vocabulary:country]
detailed description [clinicaltrials_vocabulary:detailed-description]
Combined modality thera ...... obtained by lumbar puncture.
download date [clinicaltrials_vocabulary:download-date]
ClinicalTrials.gov processed this data on August 10, 2015
eligibility [clinicaltrials_vocabulary:eligibility]
enrollment [clinicaltrials_vocabulary:enrollment]
firstreceived date [clinicaltrials_vocabulary:firstreceived-date]
1999-11-02T00:00:00Z
has expanded access [clinicaltrials_vocabulary:has-expanded-access]
intervention [clinicaltrials_vocabulary:intervention]
intervention browse [clinicaltrials_vocabulary:intervention-browse]
keyword [clinicaltrials_vocabulary:keyword]
Acquired Immunodeficiency Syndrome
Antineoplastic Agents, Combined
Brain Neoplasms
Combined Modality Therapy
Cyclophosphamide
Cytarabine
Dexamethasone
Doxorubicin
Granulocyte Colony-Stimulating Factor
Lymphoma, High-Grade
lastchanged date [clinicaltrials_vocabulary:lastchanged-date]
2012-10-31T00:00:00Z
lead sponsor [clinicaltrials_vocabulary:lead-sponsor]
location [clinicaltrials_vocabulary:location]
nct id [clinicaltrials_vocabulary:nct-id]
NCT00000801
official title [clinicaltrials_vocabulary:official-title]
Phase II Trial of Sequential C ...... entral Nervous System Lymphoma
org study id [clinicaltrials_vocabulary:org-study-id]
overall official [clinicaltrials_vocabulary:overall-official]
overall status [clinicaltrials_vocabulary:overall-status]
oversight [clinicaltrials_vocabulary:oversight]
phase [clinicaltrials_vocabulary:phase]
reference [clinicaltrials_vocabulary:reference]
secondary id [clinicaltrials_vocabulary:secondary-id]
ECOG E 1493
source [clinicaltrials_vocabulary:source]
study design [clinicaltrials_vocabulary:study-design]
study type [clinicaltrials_vocabulary:study-type]
url [clinicaltrials_vocabulary:url]
verification date [clinicaltrials_vocabulary:verification-date]
2012-10-01T00:00:00Z
identifier
clinicaltrials:NCT00000801
title
Phase II Trial of Sequential C ...... entral Nervous System Lymphoma
@en
type
label
Phase II Trial of Sequential C ...... a [clinicaltrials:NCT00000801]
@en